Key survival outcomes for patients with R/R MCL. Kaplan-Meier plots, with 95% CIs (dashed lines) for PFS (A), OS (B), DOR (C), TTF (D), and 16-week landmark analysis (E) for TTF in responders. Tick marks represent censoring at last follow-up before data cutoff for patients without an event. Note: Patient 2 could not be stringently evaluated by PET until removal of a ureteric stent near site of original disease, with CR by CT/PET formally documented after 2 years on study. For landmark analysis (E), patient 2 was included as a responder at week 16 to reflect the overall clinical assessment at the time. CT, computed tomography.